Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Human-animal hybrid embryos could lead to new stem-cell treatments

British scientists say they have created human-animal "hybrid" embryos which could be used to develop new stem-cell treatments.

2 Apr 2008

Angioplasty and stenting for renal artery lesions

The largest-ever randomized study to evaluate the effectiveness of catheter-based interventions in patients with narrowing of the renal artery has shown that angioplasty and stenting offer no benefit over medical therapy.

2 Apr 2008

Drug does not appear to reduce risk of heart attack or death following CABG surgery

Use of MC-1 (a naturally occurring metabolite of vitamin B6) before and for 30 days after coronary artery bypass graft surgery did not reduce the risk of heart attack or cardiovascular death, according to a JAMA study being released early online April 1 to coincide with its presentation at the annual conference of the American College of Cardiology.

2 Apr 2008

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics

Results of a randomised trial published in PLoS Medicine show no benefit in cognitive or neuropsychiatric outcomes from continuing neuroleptic drugs in patients with Alzheimer's disease.

1 Apr 2008

New genetic clues to diabetes

An international team that included scientists from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today reported it has identified six more genetic variants involved in type 2 diabetes, boosting to 16 the total number of genetic risk factors associated with increased risk of the disease.

1 Apr 2008

Diabetics have same risk for heart attack, stroke or death from cardiovascular diseases

People with diabetes have the same high risk for heart attack or stroke or cardiovascular death as people who've already had a heart attack, researchers reported in Circulation: Journal of the American Heart Association.

1 Apr 2008

Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly

Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented at the American College of Cardiology in Chicago and published simultaneously in the New England Journal of Medicine.

1 Apr 2008

New blood pressure drug Micardis (Telmisartan) good at reducing deaths from heart attacks

An international team of researchers have found that a new blood pressure medication is as effective in reducing cardiovascular death, with fewer side effects than the current treatments offered.

1 Apr 2008

Hypertension treatment for the elderly cuts the risk of heart disease and stroke

New research from Britain suggests that when the elderly are treated for hypertension (high blood pressure) the medication reduces their risk of heart disease, stroke and even death.

1 Apr 2008

Study shows Actos prevented progression of atherosclerotic plaque volume in patients

New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline.

1 Apr 2008

New blood pressure drug telmisartan has fewer side effects

A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with fewer side effects than the current standard of care.

1 Apr 2008

Researchers publish MRI images of genes in action in the living brain

Biologists have just confirmed what poets have known for centuries: eyes really are windows of the soul—or at least of the brain.

1 Apr 2008

Two drug combo blood pressure therapy lowers cardiovascular risk

An international blood pressure study comparing two single-pill drug combinations has yielded results so significant that the study has been stopped early and the researchers say their findings might alter the way high blood pressure is treated worldwide.

1 Apr 2008

New genetic clues to diabetes

31 Mar 2008

Gene mutations tied to immune comeback during therapy for HIV-1

A new study by U.S. scientists provides compelling evidence that two genes are linchpins in defining the course of immune restoration in HIV-positive individuals undergoing virus-suppressing therapy.

31 Mar 2008

Decreased sexual satisfaction in postmenopausal women not clearly associated with cardiovascular disease

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide have found that decreased sexual satisfaction in postmenopausal women, is not clearly associated with cardiovascular disease.

31 Mar 2008

Relaxation response training may improve control of hard-to-treat systolic hypertension

Adding the relaxation response, a stress-management approach, to other lifestyle interventions may significantly improve treatment of the type of hypertension most common in the elderly.

31 Mar 2008

Type 2 diabetes genes linked with prostate cancer

Scientists have identified six new genes which play a role in the development of type 2 diabetes, and among the group is the second gene known to also play a role in prostate cancer.

31 Mar 2008

Study shows that a larger abdomen in midlife increases risk of dementia

People in their 40s with larger stomachs have a higher risk for dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology .

28 Mar 2008

Cholesterol-associated gene variants can predict cardiovascular events

A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.

20 Mar 2008

Stroke News and Research

Further Reading

Human-animal hybrid embryos could lead to new stem-cell treatments

Angioplasty and stenting for renal artery lesions

Drug does not appear to reduce risk of heart attack or death following CABG surgery

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics

New genetic clues to diabetes

Diabetics have same risk for heart attack, stroke or death from cardiovascular diseases

Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly

New blood pressure drug Micardis (Telmisartan) good at reducing deaths from heart attacks

Hypertension treatment for the elderly cuts the risk of heart disease and stroke

Study shows Actos prevented progression of atherosclerotic plaque volume in patients

New blood pressure drug telmisartan has fewer side effects

Researchers publish MRI images of genes in action in the living brain

Two drug combo blood pressure therapy lowers cardiovascular risk

New genetic clues to diabetes

Gene mutations tied to immune comeback during therapy for HIV-1

Decreased sexual satisfaction in postmenopausal women not clearly associated with cardiovascular disease

Relaxation response training may improve control of hard-to-treat systolic hypertension

Type 2 diabetes genes linked with prostate cancer

Study shows that a larger abdomen in midlife increases risk of dementia

Cholesterol-associated gene variants can predict cardiovascular events

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News